A Study of NT 201 Doses in the Treatment of Platysma Prominence
NCT05773053
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Platysma Prominence
Interventions
DRUG:
NT 201
DRUG:
NT 201 Placebo
Sponsor
Merz Aesthetics GmbH